rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
WOCKHARDT LTD. - Wockhardt Ltd reply to clarification sought by the exchange
< Back
01 Jan 2015
The Exchange had sought clarification from Wockhardt Ltd with respect to news appearing in Economic Times on December 31, 2014 titled &quot;Wockhardt, Cadila &amp; Hospira voluntarily recall drugs in US.&quot;&lt;BR&gt;&lt;BR&gt;Wockhardt Ltd replied stating &quot;we would like to state that:-&lt;BR&gt;&lt;BR&gt;The recall of Metoprolol Succinate tablets by Wockhardt USA, the US based subsidiary of the Company was voluntary and Class III type recall which means the use of the product is not likely to cause any adverse health consequences, hence there is no material impact.&lt;BR&gt;&lt;BR&gt;The Company keeps the exchange informed about events, information etc. including price sensitive information in accordance with regulatory requirements. In present case, we do not have any important information/announcement to be shared.&lt;BR&gt;&lt;BR&gt;In the event that there is any development that requires disclosure under Clause 36 of the Listing Agreement, we will make the same in accordance with the regulatory requirements.&quot;
View all announcements for WOCKHARDT LTD. Source: BSE India